comparemela.com

Latest Breaking News On - Biotech and pharma - Page 36 : comparemela.com

Eli Lilly Is Waiting for Obesity-Drug Approval How Much It Could Be Worth

Eli Lilly’s diabetes drug Mounjaro is expected to be approved to treat obesity in the near future. It could drive sales for more than a decade.

Andrew baumLilly mounjaroJonathan weiss dreamstimeCiti baumEli lillyAdam clarkNovo nordiskArticle normalAgricultural machineryHealthcare life sciencesIndustrial goodsRegulation government policyFinancial performanceSales figuresNew products servicesProduct service approvals

Roivant, Textainer, Okta, Microsoft, Alphabet, and More Stock Market Movers

Chevron will buy Hess in all-stock deal valued at $53 billion, Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease.

Wall streetArticle normalMetalworking machineryWooden furnitureRetail wholesaleLodgings restaurants barsHotels motelsMarket research public relationsPublic relationsInternet search enginesHealthcare life sciencesAdvertising marketing public relationsBusiness consumer servicesConsumer goodsFossil fuelsIndustrial goods

Microsoft, Boeing, Amazon, Chipotle, Meta, Alphabet, and More Stocks to Watch This Week

Third-quarter earnings from Big Tech, auto makers, and more. Plus, a first look at GDP growth and the Federal Reserve's preferred inflation measure.

Meta platformsArticle normalOil and gas upstream operationsOil extractionElectricity gas utilitiesElectric power generationMetalworking machineryComputers consumer electronicsApplications softwareAerospace products partsCivil aircraftWooden furnitureRetail wholesaleLodgings restaurants barsRestaurants caterersLimited service restaurants

Intuitive Surgical Sees Robot Procedures Slow Blame Wegovy and Ozempic for Now

Intuitive's bariatric surgeries have slowed due to weight-loss drugs, but the company doesn't see a lasting effect.

Raymond jamesGary guthartJayson bedfordMyriam curetNovo nordiskIntuitive surgicalEli lillyRobbie marcusInspire medical systemsBill alpertArticle normalFinancial performanceCorporate industrial newsPolitical general newsPhysical mental fitnessLiving lifestyle

Baxter and 5 More Medical Device Stocks Primed to Bounce Back

Some investors have worried that new weight-loss drugs could undermine demand for some medical devices.

United statesJosh nathan kazisJoe wolkAnthony petroneBaxter internationalZimmer biomet holdingsCompany tickerAbbott laboratoriesEli lillyNovo nordiskDevice stocks primedBiomet holdingsArticle normalMedical equipment suppliesPort harbor operationsTrusts funds financial vehicles

vimarsana © 2020. All Rights Reserved.